News

Results of the study of 17 subjects with moderate to severe acne indicated that 16 of 17 subjects (94%) experienced a reduction in total acne lesion count of

The company now hopes to further establish the potential of Proxinium in a clinical trial involving 10 sites across North America. “While there are limited treatment options for

Batten disease is a rare and fatal neuro-degenerative genetic condition affecting infants and children. The proposed phase I trial has been on hold since February 2005, pending a

Vaccinia Immune Globulin is a hyperimmune product to be used in treating and preventing a type of severe reaction that may be brought on by administration of the

The compounds were identified by Dr Charles Sawyers at the University of California, Los Angeles. Medivation intends to begin clinical development with these compounds by the end of

The ability of the HIV virus to establish resistance to therapeutic drugs through genetic mutation is a major concern in the treatment of HIV/AIDS. With the increasing number

Remicade is now indicated for reducing signs and symptoms, achieving clinical remission and mucosal healing, and eliminating corticosteroid use in patients with moderately to severely active ulcerative colitis

Tolterodine tartrate is indicated for the treatment of an overactive bladder with symptoms of urge urinary incontinence, urgency and frequency. Total annual market sales for Tolterodine Tartrate tablets

Pfizer anticipates the European Commission to grant a marketing authorization by the end of the year. Pfizer will then market the drug exclusively in Europe upon approval. Pfizer